Member Info for 86KB

Very true pebsi, they will disappear as soon as they get bored.

Imagine being the only company that can treat and identify all autoimmune diseases. Certainly very valuable and worth many multiples from these levels.

IMM nly company that offer P140 treat all autoimmune diseases without any side affects have data to support that. P140 gets the immune system back into balance.

Sarah Davy, is a highly experienced accounting and tax professional with a strong background in strategy and significant experience in dealing with complex, high-value and international transactions. She is a Trust and Estate Practitioner and also a Taxation Technician. Sarah works alongside Richard Edwards as a Partner at a boutique firm of Chartered Accountants.

Marcus Yeoman is Chairman of Medcaw Investments PLC and was senior Non-executive Director of reach4entertainment plc and a number of other quoted companies over the last 20 years. He is also a Non-executive Director of a number of private companies which have engaged him principally to assist them with their growth strategies. His early career started with the formation of three companies in IT infrastructure and distribution, after which he moved into small company broking and corporate work with Rathbone Stockbrokers Limited and Cheviot Capital (Nominees) Limited. In 2003, Marcus established Springtime Consultants Ltd to act as a consultant to a number of listed companies and SME ventures with ambitious business plans in a variety of high growth sectors.

The Board are also in discussions with other individuals, with a view to bringing to capAI, industry-leading specialist AI knowledge either as a Director or Adviser to the Board.

This is giving me scgl vibes. Low FF goes nt alot and moves up pretty quick.

If you have sold well done on your profit but no need to come back and start talking nonsense. Just move on to the next one. Its almost as if you need to make sure you made the right decision to sell by casuing doubt for others. Once again dyor and watch interviews, read rns, presentation and see why autoimmune disease industry in huge demand than tell us that the mcap is worth the current price. Price will fluctuate as traders come and go. Funding is not a problem as they have warrants and the monthly amounts that kick in when price is above 2.66 until August.

My gut feeling as mentioned yesterday some went short or wanted in so called nomad. Notice how the naysayers have increased.

Draye you need to read the rns again, it clearly gives the reason for the rise but mentioned no "further" reason.

You also know about the warrants and you also watched the interview about not placing. So shhh

Peter just a reminder of what you said

"I’m in, looking forward to the journey here, what the have is globally unique on both the diagnostic side of auto immune diseases and treatment side with P140 been the only non Immu suppressive therapy on the market, should hit double figures now we have this clarification imo"

Some of the comments here just make you laugh. Share price low was 0.82 and we went to 4.8, then consolidated. In between that consolidation we saw so many saying whats is going on why has the so dropped, but yet couldn't understand that it was still over 200% from lows but just consolidating for the next wave. We then moved from 2.4 to 7.4p and guess whats next? consolidation. Once we done consolidating we move higher possibly double digits next.

Interesting didn't notice that, at some point that 16.5 will be at top order book.

That drop got gobbled up pretty quick. There will always be profit takers and when done we move higher each time. Lets say where the next wave takes us.

Yes Jungle having issues too but try using the app, that seems to be ok

Some suggested placing even though they don't need one to scare some into panic selling. Buyers will be back today as they realise no placing rns and have digested what the news we recently had means.

This was mentioned in the September Interims where they had already been in discussions for 6 months, which is almost taking it to a year now. Would think some of these discussions are at advanced stages as mentioned in the interview at various different levels.

We remain committed as a Board, on the development of P140 in SLE and CIDP, our two key late-stage clinical assets, together with securing additional partnering for P140. We have made significant scientific progress over the last period, including refinement of the protocols for the SLE and CIDP studies and new insights into the MOA of P140, and as a result, we have a high level of confidence of the success of these new studies.

We will also continue to concentrate on securing further commercial and partnering deals, on which we have made significant progress over the last 6 months.

We look forward to providing further updates on the progress of our pipeline and commercial deals throughout the remaining period of 2024 and moving into 2025.

Yes hence why I think we hit 7.4 today as from yesterday. If they were sells we would have been down maybe. But yes I think someone is building position too. Orders are being filled whilst some sell. We will probably see some tomorrow after hours too for today.

Hard to tell whether they are buys or sells. But we hit high of 7.4 today so could well be buys.

Gut feeling someone rang nomad as either they wanted in or went short, thought they would get negative response. But thats the most bullish speeding ticket lol.

Those who have done their research and understand about what this means for Imm, will be taking advantage of any pullbacks.

Pounds here not pence.